Preventing Complications in Robotic Prostatic Surgery
|
|
- Kathryn Powell
- 7 years ago
- Views:
Transcription
1 EUROPEAN UROLOGY SUPPLEMENTS 9 (2010) available at journal homepage: Preventing Complications in Robotic Prostatic Surgery Rafael Sanchez-Salas, Vincent Flamand, Xavier Cathelineau * Department of Urology, Institut Montsouris, Université Paris Descartes, Paris, France Article info Keywords: Prostate cancer Surgical treatment Radical prostatectomy Complications Learning curve Robotic prostatectomy Prevention of complications Please visit europeanurology to read and answer questions on-line. The EU-ACME credits will then be attributed automatically. Abstract Context: The urologic community has embraced robot-assisted laparoscopic radical prostatectomy (RALP) using the da Vinci Surgical System (Intuitive Surgical, Sunnyvale, CA, USA) as a surgical therapeutic approach to localised prostate cancer (PCa). Safety, efficacy, and potential complications of RALP should be clearly known and emphasised in order to improve outcomes. Objective: To provide an overview of the prevention and reduction of complications in RALP to aid the understanding of the multivariable nature of a surgical procedure incorporating highly developed technology. Evidence acquisition: The present manuscript is based on a presentation on the prevention of complications in robotic prostatic surgery held at the European Association of Urology Section of Oncological Urology meeting in Vienna, Austria, in January The scope of this article is such that no attempt has been made to include all available evidence on the topic but rather a selection based on practical considerations. Experience with RALP gained at the Institut Montsouris is also reflected in the body of the manuscript. Evidence synthesis: Despite the lack of standardisation when talking about complications, RALP seems to be at least equivalent to laparoscopic radical prostatectomy, and recently, it appears to provide even better results. To prevent complications, RALP should be considered in its entirety from patient evaluation to postoperative care, not just the surgery itself. The surgeon remains the first actor, and no place is left for improvisation. Thus, every step of the procedure must be perfectly understood and mastered. One must remember that years of training stand behind these high levels of control and technique. Conclusions: Prevention and management of complications in RALP require a high level of team expertise. Perfect standardisation of the procedure and the communication of the procedure s results are mandatory to lowering the incidence of complications and to facilitating its diffusion to the urologic community. # 2010 European Association of Urology. Published by Elsevier B.V. All rights reserved. * Corresponding author. Department of Urology, Institut Montsouris, 42, Bd Jourdan, 75014, Paris, France. Tel ; Fax: address: xavier.cathelineau@imm.fr (X. Cathelineau). 1. Complications in robotic prostatic surgery The recognition, report, and analysis of complications remain an essential element of surgical development. As robotic prostatectomy has expanded tremendously in the last few years, there is an important interest in the urologic community in improving the outcomes of this procedure, with avoiding complications and diminishing morbidity as its main objectives. The reporting and description of complications vary greatly among authors. A range of overall complication rates from 4% to 34% and from 1% to 8.8% has been reported for laparoscopic radical /$ see front matter # 2010 European Association of Urology. Published by Elsevier B.V. All rights reserved. doi: /j.eursup
2 EUROPEAN UROLOGY SUPPLEMENTS 9 (2010) prostatectomy (LRP) and robot-assisted laparoscopic radical prostatectomy (RALP), respectively. Ficarra et al have recently reported that the overall complication rates recorded in the comparative studies evaluating retropubic prostatectomy and RALP were similar in most of the available publications, with a nonstatistically significant trend in favour of RALP being identified after cumulative analysis [1]. Using the Clavien system, several groups have reported their complications in laparoscopic or robot-assisted radical prostatectomy (RP). In our early experience in LRP, Guillonneau et al [2] reported complication rates for grades 1, 2a, 2b, and 3 of 1.95%, 10.52%, 5.67%, and 0.17%, respectively; Gonzalgo et al [3]. reported complication rates of 8.1%, 1.2%, 3.7%, and 0.8% for grades 2, 3a, 3b, and 4a, respectively. Stolzenburg et al [4] reported on 900 patients who underwent LRP, showing complication rates of 4.6%, 2%, 6.2%, and 0.3% for grades 1, 2, 3, and 4a, respectively. Regarding RALP, Kaul et al [5], in 154 patients, reported complication rates of 2.5%, 5%, 0.6%, and 2% for grades 1d, 1, 2b, and 3a, respectively. Bhandari et al [6], in a study with 300 patients, recorded 3.7% and 2% for grade 1 and grade 2 complications, respectively. John et al reported on 210 cases of RALP performed (second half of their series) and compared their results with a retrospective Medline-based meta-analysis of 4928 patients from 8 centers. Overall, 55 of 210 patients (26%) had complications, of which 48 of 55 (87%) were minor (Clavien grade 1 3a). Major complications (grades 3b and 4a) with open reoperations occurred in 7 of 210 patients (3%). John and colleagues state that the robotic complication rate is low and seemed to be even lower than in open series [7]. Novara et al [8], applying standardised criteria (Memorial Sloan-Kettering Cancer Center), identified early complications in about 22% of patients undergoing RALP. In their series, 3% of patients did experience grade 3 or 4 complications. As we all know, to accomplish a categorical 0 in surgeryrelated complications, we would probably have to stop doing surgery. For that reason, the aim is to reduce complications to their lowest possible levels. The experience gathered up to now should allow us to provide a list of precautions that would benefit the outcomes of RALP in the future. 2. Definition of complications First, we need to speak the same language; similarly, defining the events we are going to measure is of great importance. We must have a clear idea that complications can be reduced even before the surgery is performed, comprehensively analysing all interacting variables in RP. Furthermore, we have to keep in mind that the outcomes of RP could be assumed as clear complications in terms of functionality. The report of complications in surgical literature seems to be a pending issue. Martin et al performed an analysis of articles reporting short-term outcomes after pancreatectomy, oesophagectomy, and hepatectomy, including randomised clinical trials published from 1975 to 2001 and retrospective series of >100 patients published from 1990 to They deploy 10 criteria to evaluate publications: (1) the method of accruing data (prospective or retrospective); (2) the duration of outpatient information (ie, the time period of the postoperative accrual of complications); (3) definitions of complications; (4) mortality rate and causes of death; (5) morbidity rate; (6) total complications (ie, the number of patients with any complication and the total number of complications); (7) procedure-specific complications; (8) the severity grade utilised; (9) length-of-stay data; and (10) risk factors. A total of 119 articles reporting outcomes in patients were analysed. Surprisingly, no articles met all criteria. Only 2% of the information verified met nine criteria [9]. In the urologic oncology literature, Donat also verified the disparity in the quality of surgical complication reporting, with 87% of studies accruing data retrospectively, and only 66% reporting on a minimum of 5 of 10 critical surgical reporting criteria established in the surgical literature. The criteria least commonly met were the failure to include complication definitions (79%), complication severity or grade (67%), outpatient data (63%), patient risk factor stratification (59%), and the duration of the complication period (56%) [10]. More recently, Rabbani et al [11] have applied the Martin et al [8] criteria to evaluate the incidence, severity, and timing of onset of medical and surgical complications of 4592 patients operated on using open RP and LPR between 1999 and 2007 in a tertiary referral center. They verified 612 medical complications in 467 patients (10.2%) and 1426 surgical complications in 925 patients (20.1%). The laparoscopic approach was associated with a higher incidence of any grade of medical and surgical complications but a lower incidence of major surgical complications than RP. This timely publication emphasises the idea of objective standardised reporting as a way to verify the real picture of complications and their impact on cancer treatment. The complications for any form of RP include intraoperative events such as haemorrhage; obturator nerve, rectal, and ureteral injuries; and postoperative complications such as the risk of delayed bleeding, incontinence, and erectile dysfunction (ED). As cancer control remains the first objective of the trifecta, we should think that adjuvant oncologic treatment after RP is to be regarded as a complication. If we look at the classification of complications proposed by Stephenson et al [12], we can see that the interventions we perform to treat problems of potency or continence after RP can be perfectly included in the different grades presented: phosphodiesterase 5 inhibitors for ED equals grade 1 (oral medication or bedside care); intracavernous therapy for ED equals grade 2 (intravenous therapy); and penile prosthesis and sphincter placement equal grade 3 (intubation, interventional radiology, endoscopy, or reoperation). Then, we need to look at complications as a network of events having a defined impact on outcomes. Robotic prostatectomy has been received in our community with
3 390 EUROPEAN UROLOGY SUPPLEMENTS 9 (2010) great enthusiasm, and the work of Constantinides et al [13] shows that in a comparison of complications in laparoscopic, open, and robotic prostatectomy, complications seem to be fewer and with lower grades for RALP. Comparison remains a controversial issue in RP, and whether we use one classification or another (Clavien [14] or Stephenson et al [12]), the idea is to keep objectively evaluating our procedures Are we comparing apples with apples? An interesting publication by Hu et al [15] states that complications are lower for what they called minimally invasive radical prostatectomy (MIRP) but with the expensive price of exposing patients treated with MIRP to a higher probability of salvage therapy. Two comments should be emphasised in the setting of this study. First, laparoscopic and robotic prostatectomies are not the same. We would agree that the objectives of trifecta remain the same, but perhaps the augmented range of movement and tridimensional vision have an impact on outcomes for these patients. We pioneered a laparoscopic approach in Montsouris in 1998, and then RALP in Waiting for objective comparative results between LRP and RALP, we have been very cautious towards robotic prostatectomy at our institution, even if we were convinced of the real potential of the technology. Our early comparison of perioperative outcomes between LRP and RALP showed that in an experienced team, the techniques were equivalent [16]. Today, we can see that our results are shifting towards the robotic interface in terms of both cancer control (a decrease in the rate of positive surgical margins [PSM]) and functionality (self-questionnaire evaluation). Again, we are more experienced today, which certainly has an influence on outcomes, but the robot definitively contributes. We are in the process of reporting our latest result with RALP. Second, the manuscript by Hu et al [15] was developed over the analysis of a limited population of patients (2702 men who underwent RP from 2003 to 2005 from a national sample representing 5% of Medicare beneficiaries). These prostatectomies were not necessarily performed by the referent surgeons of this technique. More recently, Hu et al reported on a population-based observational cohort study using the US National Cancer Institute Surveillance Epidemiology and End Results Program data from 2003 through 2007 [17]. They compared MIRP and radical retropubic prostatectomy in terms of postoperative 30-d complications, anastomotic stricture, long-term incontinence, ED, and the postoperative need for adjuvant cancer therapies, concentrating on high-volume surgeons. The report showed no difference in additional cancer therapy between robotic MIRP and open RP, but this time, their results in terms of additional cancer therapies were comparable for both techniques. There were fewer complications for minimally invasive surgery, with a significantly increased risk of incontinence and ED with MIRP. Again, a restricted view of the real situation of RP in the United States is a limitation of this study. 3. Robot-assisted laparoscopic prostatectomy: a multivariable event The evaluation and planning of any form of RP should be performed in a minutely precise manner in which all elements should be incorporated into the analysis (the patient, the surgeon, and the technique). The robotic interface brings a great deal of new detail into an already crowded arena The patient Patient and approach selection are essential. There are no specific indications for RALP compared to open or laparoscopic RP. The patient should be carefully evaluated to define potential risk associated with comorbidities, body mass index, specific features of the disease, previous treatments (eg, transurethral resection of the prostate, androgen deprivation, radiation therapy). In RALP, special attention should be paid to the possible effects of pneumoperitoneum and sever cardiopulmonary disease, which remain contraindications for both LRP and RALP. The particularisation of every case would benefit outcomes, and as we have previously stated, complications can be reduced when evaluating the indications for RALP. Elements such as being overweight and previous surgical history have recently been evaluated as factors that could affect outcomes, and they should be emphasised especially at the beginning of an experience with RALP. Obesity affects operative and postoperative outcomes (complications and trifecta) and is associated with higher-grade tumours and a higher rate of PSM [18]. Previous abdominal or inguinal surgery does not increase the risk of complications in RALP The surgeon It does not matter how advance and effective the technology might be, there is always a person behind the wheel, and the final results depend on his or her performance. The surgeon needs to know the disease and understand its variations; at the same time, in terms of technique, training is mandatory and surgical volume essential to accomplishing a learning curve in any operation. The example speaks by itself: The magnificent Ferrari automobile is just a machine without a champion driver behind the wheel. The German Formula 1 driver and seventime Formula 1 world drivers champion Michael Schumacher accomplished his successful career not only with Ferrari but also with other Formula 1 teams. The message: The technique of surgery depends on the surgeon. As sufficient training and competence are mandatory, proctoring is an essential mechanism for assuring safe and effective outcomes with RALP [19] The surgical team s training Sufficient technical preparation and training are mandatory not only for the surgeon but for the whole surgical team. Standardisation of the whole procedure adds security for
4 EUROPEAN UROLOGY SUPPLEMENTS 9 (2010) the patient. Clear and loud communication must be maintained between the console surgeon and his or her assistant Checklist and maintenance Complications can be only avoided by minutely precise prevention. In RALP, as in any surgery, the formal application of a checklist plays an important role in the procedure [20]. The robot works like an airplane, which must be adequately maintained and verified before every flight. Adequate installation of every component is essential Trocar positioning RALP inherited from classic laparoscopy the minimal access philosophy. Formal knowledge of anatomic landmarks and potential complications at this point of the procedure are of the utmost importance. Trocar positioning should be customised for every patient in order to facilitate the procedure Robot docking Verification of the ideal positioning of the chart and convenient docking of the arms is essential, keeping in mind the internal position of the trocars and the minimum mandatory space between instruments. Maintain bipolar and monopolar installation in the corresponding instruments. The robot can be safely undocked when the trocars are totally unscrewed before pulling the interface Instrument insertion The first insertion of the instruments is not intuitive and must be visually controlled in order to avoid visceral or vascular lesions. With each touch of the button in the robotic arms, the position changes; therefore, the chance of complications should be emphasised to the surgical team. Trocar mobilisation or extraction should be performed under direct vision at all times Learning curve Solid training is the cornerstone of success for the surgeon; today, several options are available for becoming trained in robotic prostatectomy. Urologists who are proficient in laparoscopic RP will still have a learning curve when first performing RALP. In our initial experience, a total of 293 consecutive men underwent RALP between May 2000 and November Operative time showed a statistically significant decline at two different breakpoints: after the first 12 cases and after 189 cases, dividing the patients into 3 groups. Operative times were min, min, and min, respectively, for each group. We also evaluated margin status in the three groups. The PSM rate in each group was 7 of 12 (58%), 41 of 180 (23%), and 10 of 89 (9%), which was statistically significant [21]. Improvement continues in operative and pathologic parameters with regard to operative duration and PSM rate as experience grows. The deployment of the robot has reduced the learning curve as a result of the endowrist technology, three-dimensional vision, and magnification, but there is still a need for solid evidence to back up the analysis on the learning curve. Completing the procedure or being able to perform it does not necessarily mean that the procedure is done well. Vickers et al in their timely publication assessing surgical learning curve for prostate cancer (PCa) control [22] found statistical significance related to surgeon experience and cancer control after RP. This study brings back to earth the concept of learning curves and reflects a real link between surgical technique and cancer control. This analysis verified a dramatic improvement in cancer control with increasing surgeon experience. Prior to the 250 previously treated cases reported by Tooher et al [23], the laparoscopic learning curve had only been addressed in a limited number of studies. The need for surgical expertise also applies to RALP in order to reach the same level of performance. This learning curve for robotic MIRP has been estimated at patients [24,25]. 4. Robot-assisted laparoscopic prostatectomy features that reduce potential functional complication of radical prostatectomy To optimise nerve-sparing techniques, the surgeon confronts the dilemma: margins versus potency. On which side of the fascia should one stand? Even with all the improvements made since Walsh s first operation >25 yr ago, RP remains a challenging procedure with a steep learning curve and two objectives that are contradictory [26]. The idea is to obtain reliable cancer control, which means avoidance of PSM while preserving functionality as much as possible in terms of continence and potency. To accomplish these objectives, we believe that the interfacial plane would be the elected plane for comprehensive nerve sparing in order to be oncologically safe while preserving functionality. One should avoid intensive manipulation or haemostasis over the sphincter or the bundles. The robotic features are rather strong, but only precise and delicate manoeuvres should be performed [27]. The big picture is that tension and energy-free surgical manoeuvres are perhaps the keys to every procedure. Suturing should take advantage of the endowrist technology to improve anastomosis reconstruction. Different means to improve continence can be deployed, including the concept of urethral suspension, which has recently been proposed by Patel et al and that we consider useful for continence [28]. 5. Future endeavours Obviously, today we are at the threshold of robotic surgery. This technology would be incorporated into the different aspects of surgical treatment to improve our performance and, subsequently, our results. The same technology allows for training and clinical application, which surely improves the path to follow. Robotic surgery inherits years of work and effort. We should be able to recognise that this is not a novel
5 392 EUROPEAN UROLOGY SUPPLEMENTS 9 (2010) procedure but rather the same operation with the same objectives, highly refined because of strict evaluation of results and comprehensive analysis of its possible impact on the lifestyle of patients. The incorporation of new devices such as robots into surgical practice requires that surgeons acquire and master new skills. Like any new technology, robotic surgery demands dedication to achieve expertise. We still need to be cautious regarding patient expectations, because when surrounded by rather impressive robotic paraphernalia, the hopes you set are high and patients are likely to feel less satisfied. Schroeck et al in a study with 400 patients demonstrated that open prostatectomy patients were 4.4 times more likely to be satisfied with the operation. In contrast, RALP patients were shown to be three times more likely to hold regrets about their treatment [29]. With higher expectations related to marketing effect and promotion of innovation, there is a greater risk of dissatisfaction. So, even with a high level of technology, we need an expert team behind the wheel and an objective evaluation of outcomes. 6. Conclusions Prevention and management of complications in RALP requires a high level of team expertise. Perfect standardisation of procedure and communication of the procedure s results are mandatory to lowering the incidence of complications and facilitate the procedure s diffusion to the urologic community. Evidence of robotic contribution to surgery is undeniable, and future improvements combining imaging is the gift all surgeons are expecting to further contribute to the lives of our patients. Conflicts of interest The authors have nothing to disclose. Funding support None. References [1] Ficarra V, Novara G, Artibani W, et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol 2009;55: [2] Guilloneau B, Rozet F, Cathelineau X, et al. Perioperative complications of laparoscopic radical prostatectomy: the Montsouris 3-year experience. J Urol 2002;16:51 7. [3] Gonzalgo ML, Pavlovich CP, Trock BJ, Link RE, Sullivan W, Su LM. Classification and trends of perioperative morbidities following laparoscopic radical prostatectomy. J Urol 2005;174: [4] Stolzenburg JU, Rabenalt R, Do M, et al. Categorization of complications of endoscopic extraperitoneal and laparoscopic radical prostatectomy. World J Urol 2006;24: [5] Kaul S, Savera A, Badani K, Fumo M, Bhandari A, Menon M. Functional outcomes and oncological efficacy of Vattikuti Institute prostatectomy with Veil of Aphrodite nerve-sparing: an analysis of 154 consecutive patients. BJU Int 2005;97: [6] Bhandari A, McIntire L, Kaul S, Hemal AK, Peabody JO, Menon M. Perioperative complications of robotic radical prostatectomy after the learning curve. J Urol 2005;174: [7] Fischer B, Engel N, Fehr JL, John H. Complications of robotic assisted radical prostatectomy. World J Urol 2008;26: [8] Novara G, Ficarra V, D Elia C, Secco S, Cavalleri S, Artibani W. Prospective evaluation with standardised criteria for postoperative complications after robotic-assisted laparoscopic radical prostatectomy. Eur Urol 2010;57: [9] Martin II RC, Brennan MF, Jaques DP. Quality of complication reporting in the surgical literature. Ann Surg 2002;235: [10] Donat SM. Standards for surgical complication reporting in urologic oncology: time for a change. Urology 2007;69: [11] Rabbani F, Yunis LH, Pinochet R, et al. Comprehensive standardized report of complications of retropubic and laparoscopic radical prostatectomy. Eur Urol 2010;57: [12] Stephenson AJ, Hakimi AA, Snyder ME, Russo P. Complications of radical and partial nephrectomy in a large contemporary cohort. J Urol 2004;171: [13] Constantinides CA, Tyritzis SI, Skolarikos A, Liatsikos E, Zervas A, Deliveliotis C. Short- and long-term complications of open radical prostatectomy according to the Clavien classification system. BJU Int 2009;103: [14] Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240: [15] Hu JC, Wang Q, Pashos CL, Lipsitz SR, Keating NL. Utilization and outcomes of minimally invasive radical prostatectomy. J Clin Oncol 2008;26: [16] Rozet F, Jaffe J, Braud G, et al. A direct comparison of robotic assisted versus pure laparoscopic radical prostatectomy: a single institution experience. J Urol 2007;178: [17] Hu JC, Gu X, Lipsitz SR, et al. Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA 2009;302: [18] Castle EP, Atug F, Woods M, Thomas R, Davis R. Impact of body mass index on outcomes after robot assisted radical prostatectomy. World J Urol 2008;26:91 5. [19] Zorn KC, Gautam G, Shalhav AL, et al. Members of the Society of Urologic Robotic Surgeons. Training, credentialing, proctoring and medicolegal risks of robotic urological surgery: recommendations of the Society of Urologic Robotic Surgeons. J Urol 2009;182: [20] Scardino PT. Safety in surgery: the checklist. Nat Rev Urol 2009; 6:235. [21] Jaffe J, Castellucci S, Cathelineau X, et al. Robot-assisted laparoscopic prostatectomy: a single-institutions learning curve. Urology 2009;73: [22] Vickers AJ, Bianco FJ, Serio A, et al. The surgical curve for prostate cancer control after radical prostatectomy. J Natl Cancer Inst 2007; 99: [23] Tooher R, Swindle P, Woo H, et al. Laparoscopic radical prostatectomy for localized prostate cancer: a systematic review of comparative studies. J Urol 2006;175: [24] Ahlering TE, Skarecky D, Lee D, et al. Successful transfer of open surgical skills to a laparoscopic environment using a robotic interface: initial experience with laparoscopic radical prostatectomy. J Urol 2003;170: [25] Herrell SD, Smith Jr JA. Robotic-assisted laparoscopic prostatectomy: what is the learning curve? Urology 2005;66: [26] Walsh PC. The discovery of the cavernous nerves and development of nerve sparing radical retropubic prostatectomy. J Urol 2007;177: 1632.
6 EUROPEAN UROLOGY SUPPLEMENTS 9 (2010) [27] Mattei A, Naspro R, Annino F, Burke D, Guida Jr R, Gaston R. Tension and energy-free robotic-assisted laparoscopic radical prostatectomy with interfascial dissection of the neurovascular bundles. Eur Urol 2007;52: [28] Patel VR, Coelho RF, Palmer KJ, Rocco B. Periurethral suspension stitch during robot-assisted laparoscopic radical prostatectomy: description of the technique and continence outcomes. Eur Urol 2009;56: [29] Schroeck FR, Krupski TL, Sun L, et al. Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy. Eur Urol 2008;54:
Robotic Radical Prostatectomy: What s s the Advantage? Matthew T. Gettman, M.D. Associate Professor Department of Urology
Robotic Radical Prostatectomy: What s s the Advantage? Matthew T. Gettman, M.D. Associate Professor Department of Urology Prostate Cancer Epidemiology: 2009 Estimated new cases: 230,000 Estimated deaths:
More informationProstate Cancer Treatment Comparison
Prostate Cancer Treatment Comparison Treatment Comparative Data Outcome Comparison: Surgery vs. Radiotherapy Outcome Radical Prostatectomy* Radiation** Survival duration compared to conservative disease
More informationPrecise, Minimally Invasive Prostate Cancer Removal
Precise, Minimally Invasive Prostate Cancer Removal Learn why da Vinci Surgery may be your best treatment option 1 Beyond Minimally Invasive For Prostate Cancer 1 Facing Prostate Cancer Prostate cancer
More informationProstate Cancer Treatment Comparison
Prostate Cancer Treatment Comparison Treatment Comparative Data Outcome Comparison: Surgery vs. Radiotherapy Outcome Radical Prostatectomy* Radiation** Survival duration compared to conservative disease
More informationda Vinci Prostatectomy Information Guide (Robotically-Assisted Radical Prostatectomy)
da Vinci Prostatectomy Information Guide (Robotically-Assisted Radical Prostatectomy) Prostate Cancer Overview Prostate cancer is a disease in which malignant (cancer) cells form in the tissues of the
More informationFacing Prostate Cancer Surgery? Learn about minimally invasive da Vinci Surgery
Facing Prostate Cancer Surgery? Learn about minimally invasive da Vinci Surgery The Condition: Prostate Cancer Your prostate is a walnut-sized gland that is part of the male reproductive system. The prostate
More informationEUROPEAN UROLOGY 65 (2014) 610 619
EUROPEAN UROLOGY 65 (2014) 610 619 available at www.sciencedirect.com journal homepage: www.europeanurology.com Prostate Cancer Comparisons of the Perioperative, Functional, and Oncologic Outcomes After
More informationThomas A. Kollmorgen, M.D. Oregon Urology Institute
Thomas A. Kollmorgen, M.D. Oregon Urology Institute None 240,000 new diagnosis per year, and an estimated 28,100 deaths (2012) 2 nd leading cause of death from cancer in U.S.A. Approximately 1 in 6 men
More informationNew Technologies in Surgery
New Technologies in Surgery Jim C. Hu MD, MPH Center for Advanced Surgical and Interventional Technology (CASIT) Director of Robotic and Minimally Invasive Surgery Associate Professor Department of Urology
More informationOncological and functional outcomes of laparoscopic radical prostatectomy following fellowship training.
Oncological and functional outcomes of laparoscopic radical prostatectomy following fellowship training. Journal: BJU International Manuscript ID: Draft Manuscript Type: Original Article Date Submitted
More informationClinical Practice Assessment Robotic surgery
Clinical Practice Assessment Robotic surgery Background: Surgery is by nature invasive. Efforts have been made over time to reduce complications and the trauma inherently associated with surgery through
More informationRobotic Assisted Laparoscopic Salvage Prostatectomy for Radiation Resistant Prostate Cancer
Robotic Assisted Laparoscopic Salvage Prostatectomy for Radiation Resistant Prostate Cancer Jonathan A. Eandi,* Brian A. Link, Rebecca A. Nelson, David Y. Josephson, Clayton Lau, Mark H. Kawachi and Timothy
More informationPrecise, Minimally Invasive Prostate Cancer Removal
Precise, Minimally Invasive Prostate Cancer Removal Why da Vinci Surgery may be your best treatment option 1 Beyond Minimally Invasive For Prostate Cancer 1 Facing Prostate Cancer Prostate cancer is the
More information7. Prostate cancer in PSA relapse
7. Prostate cancer in PSA relapse A patient with prostate cancer in PSA relapse is one who, having received a primary treatment with intent to cure, has a raised PSA (prostate-specific antigen) level defined
More informationCorresponding Author: Daniel Pucheril (email: dpucheril@gmail.com)
PRISMA-P 2015 CHECKLIST ADMINISTRATIVE INFORMATION Title: An updated systematic review of complications following Robotic-Assisted Laparoscopic Radical Prostatectomy: A guide to avoiding and managing complications
More informationNERVE GRAFT TO RESTORE ERECTILE FUNCTION DURING RADICAL PROSTATECTOMY
CLINICAL POLICY NERVE GRAFT TO RESTORE ERECTILE FUNCTION DURING RADICAL PROSTATECTOMY Policy Number: SURGERY 043.13 T Effective Date: October 1, 015 Table of Contents BENEFIT CONSIDERATIONS. APPLICABLE
More informationCancer research in the Midland Region the prostate and bowel cancer projects
Cancer research in the Midland Region the prostate and bowel cancer projects Ross Lawrenson Waikato Clinical School University of Auckland MoH/HRC Cancer Research agenda Lung cancer Palliative care Prostate
More informationFacing a Hysterectomy? If you ve been diagnosed with early stage gynecologic cancer, learn about minimally invasive da Vinci Surgery
Facing a Hysterectomy? If you ve been diagnosed with early stage gynecologic cancer, learn about minimally invasive da Vinci Surgery The Condition: Early Stage Gynecologic Cancer A variety of gynecologic
More informationSurgeon perception is not a good predictor of peri-operative outcomes in robot-assisted radical prostatectomy
DOI 10.1007/s11701-011-0293-4 ORIGINAL ARTICLE Surgeon perception is not a good predictor of peri-operative outcomes in robot-assisted radical prostatectomy Joshua Stern Saurabh Sharma Pierre Mendoza Mary
More informationStrategic Acquisition
Date: Fiscal Year 2013 To: From: Re: Hospital Executives Kathryn Barry, MPH, MSN, RN Health Policy Specialist for Intuitive Surgical Planning for Long Term Success with a Robotic Surgery Program As the
More informationProton Therapy for Prostate Cancer: Your Questions, Our Answers.
Proton Therapy for Prostate Cancer: Your Questions, Our Answers. When you re looking for the right treatment for your prostate cancer, nothing s more important than accurate information. Read on, and learn
More informationDoes my patient need more therapy after prostate cancer surgery?
Does my patient need more therapy after prostate cancer surgery? Contact the GenomeDx Patient Care Team at: 1.888.792.1601 (toll-free) or e-mail: client.service@genomedx.com Prostate Cancer Classifier
More information4/8/13. Pre-test Audience Response. Prostate Cancer 2012. Screening and Treatment of Prostate Cancer: The 2013 Perspective
Pre-test Audience Response Screening and Treatment of Prostate Cancer: The 2013 Perspective 1. I do not offer routine PSA screening, and the USPSTF D recommendation will not change my practice. 2. In light
More informationLaunching a Successful Robotic Program
2 Launching a Successful Robotic Program Kenneth J. Palmer, Marcelo A. Orvieto, Bernardo M. Rocco, and Vipul R. Patel Keywords Robotic surgery Robotic surgical program Marketing Operating room setup Training
More informationNeoadjuvant and Adjuvant Hormone Therapy: How and When?
european urology supplements 7 (2008) 747 751 available at www.sciencedirect.com journal homepage: www.europeanurology.com Neoadjuvant and Adjuvant Hormone Therapy: How and When? Hein Van Poppel * Department
More informationRobotic Surgery 12 years of robotic assisted surgery vs. conventional laparoscopic surgery
Robotic Surgery 12 years of robotic assisted surgery vs. conventional laparoscopic surgery A new chapter in medicine.from the first remote surgery by Prof. Dr. Senner to the today`s da Vinci technology
More informationFacing a Hernia Repair? Learn about minimally invasive da Vinci Surgery
Facing a Hernia Repair? Learn about minimally invasive da Vinci Surgery The Condition: Hernia A hernia happens when part of an internal organ or tissue bulges through a hole or weak area in the belly wall
More informationUpdate on Prostate Cancer: Screening, Diagnosis, and Treatment Making Sense of the Noise and Directions Forward
Update on Prostate Cancer: Screening, Diagnosis, and Treatment Making Sense of the Noise and Directions Forward 33 rd Annual Internal Medicine Update December 5, 2015 Ryan C. Hedgepeth, MD, MS Chief of
More informationKIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA
KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA O.E. Stakhvoskyi, E.O. Stakhovsky, Y.V. Vitruk, O.A. Voylenko, P.S. Vukalovich, V.A. Kotov, O.M. Gavriluk National Canсer Institute,
More informationProstate cancer. Christopher Eden. The Royal Surrey County Hospital, Guildford & The Hampshire Clinic, Old Basing.
Prostate cancer Christopher Eden The Royal Surrey County Hospital, Guildford & The Hampshire Clinic, Old Basing. Screening Screening men for PCa (prostate cancer) using PSA (Prostate Specific Antigen blood
More informationFacing Pancreatic Surgery? Learn about minimally invasive da Vinci Surgery
Facing Pancreatic Surgery? Learn about minimally invasive da Vinci Surgery The Condition: Pancreatitis/Pancreatic Cancer The pancreas is an organ that produces enzymes and hormones to help your body digest
More informationWhy Robotic Surgery Is Changing the Impacts of Medical Field
Volume Article.13-08 Publish Date: 25th March 2013 Author(s): MPUH - CRS Team Why Robotic Surgery Is Changing the Impacts of Medical Field ARTICLE hhh Muljibhai Patel Urological Hospital (MPUH) Centre
More information855-DRSAMADI or 212-241-8779
SMART SURGERY NEWS MARCH 2013 Dr. David Samadi 855-DRSAMADI or 212-241-8779 YOUR PROSTATE CANCER NEWS PREVENTION DIAGNOSIS TREATMENT LIFE AFTER PROSTATE CANCER PREVENTION Prostate Cancer Need-to-Knows
More informationThe Business of Prostate Cancer Care: A Clinician-Researcher s Perspective
The Business of Prostate Cancer Care: A Clinician-Researcher s Perspective David F. Penson, MD, MPH Departments of Urology and Preventive Medicine Keck School of Medicine University of Southern California
More informationHistorical Basis for Concern
Androgens After : Are We Ready? Mohit Khera, MD, MBA Assistant Professor of Urology Division of Male Reproductive Medicine and Surgery Scott Department of Urology Baylor College of Medicine Historical
More informationHow to treat early gastric cancer. Surgery
How to treat early gastric cancer Surgery Mark I. van Berge Henegouwen Department of Surgery, AMC, Amsterdam Director upper GI surgical unit Academic Medical Center Upper GI surgery at AMC 100 oesophagectomies
More informationThese rare variants often act aggressively and may respond differently to therapy than the more common prostate adenocarcinoma.
Prostate Cancer OVERVIEW Prostate cancer is the second most common cancer diagnosed among American men, accounting for nearly 200,000 new cancer cases in the United States each year. Greater than 65% of
More informationProstate Cancer What Are the Outcomes of Radical Prostatectomy for High-risk Prostate Cancer?
Prostate Cancer What Are the Outcomes of Radical Prostatectomy for High-risk Prostate Cancer? Stacy Loeb, Edward M. Schaeffer, Bruce J. Trock, Jonathan I. Epstein, Elizabeth B. Humphreys, and Patrick C.
More informationTherapies for Prostate Cancer and Treatment Selection
Prostatic Diseases Therapies for Prostate Cancer and Treatment Selection JMAJ 47(12): 555 560, 2004 Yoichi ARAI Professor and Chairman, Department of Urology, Tohoku University Graduate School of Medicine
More informationThe 4Kscore blood test for risk of aggressive prostate cancer
The 4Kscore blood test for risk of aggressive prostate cancer Prostate cancer tests When to use the 4Kscore Test? Screening Prior to 1 st biopsy Prior to negative previous biopsy Prognosis in Gleason 6
More informationThe Management of a Clinical T1b Renal Tumor in the Presence of a Normal Contralateral Kidney
Opposing Views The Management of a Clinical T1b Renal Tumor in the Presence of a Normal Contralateral Kidney NEPHRON SPARING SURGERY When a patient is seated in front of you with a6cm contrast enhancing
More informationIntuitive Surgical Presentation to the Congressional Robotics Caucus May 21, 2009
Intuitive Surgical Presentation to the Congressional Robotics Caucus May 21, 2009 Intuitive Surgical - Overview Founded in 1995 Employs ~1100 people worldwide, ~1000 people in the US Publicly-traded company,
More informationProstate Cancer Screening: Are We There Yet? March 2010 Andrew M.D. Wolf, MD University of Virginia School of Medicine
Prostate Cancer Screening: Are We There Yet? March 2010 Andrew M.D. Wolf, MD University of Virginia School of Medicine Case #1 A 55 yo white man with well-controlled hypertension presents for his annual
More informationDA VINCI ROBOTIC HYSTERECTOMY
DA VINCI ROBOTIC HYSTERECTOMY Until recently, surgery for most gynecologic conditions was performed using a large abdominal incision. This is because while conventional laparoscopic surgery is effective
More informationFAQ About Prostate Cancer Treatment and SpaceOAR System
FAQ About Prostate Cancer Treatment and SpaceOAR System P. 4 Prostate Cancer Background SpaceOAR Frequently Asked Questions (FAQ) 1. What is prostate cancer? The vast majority of prostate cancers develop
More informationPSA Screening for Prostate Cancer Information for Care Providers
All men should know they are having a PSA test and be informed of the implications prior to testing. This booklet was created to help primary care providers offer men information about the risks and benefits
More informationConsidering Bariatric Surgery? Learn about minimally invasive da Vinci Surgery
Considering Bariatric Surgery? Learn about minimally invasive da Vinci Surgery The Condition: Obesity Obesity is defined as having a body mass index (BMI) of 30 or greater. Obesity is a serious medical
More informationTreatment of Incidental Prostate Cancer Diagnosed during BPH Surgery with Radical Prostatectomy: Appropriate or over Treatment?
Journal of Cancer Therapy, 2012, 3, 256-262 http://dx.doi.org/10.4236/jct.2012.34036 Published Online August 2012 (http://www.scirp.org/journal/jct) Treatment of Incidental Prostate Cancer Diagnosed during
More informationLocal Salvage Therapies After Failed Radiation for Prostate Cancer. Biochemical Failure after Radiation
Local Salvage Therapies After Failed Radiation for Prostate Cancer James Eastham, MD Memorial Sloan-Kettering Cancer Center New York, New York Biochemical Failure after Radiation ASTRO criteria 3 consecutive
More informationCancer of the Cardia/GE Junction: Surgical Options
Cancer of the Cardia/GE Junction: Surgical Options Michael A Smith, MD Associate Chief Thoracic Surgery Center for Thoracic Disease St Joseph s Hospital and Medical Center Phoenix, AZ Michael Smith, MD
More informationConsidering Surgery for Fibroids? Learn about minimally invasive da Vinci Surgery
Considering Surgery for Fibroids? Learn about minimally invasive da Vinci Surgery The Condition: Uterine Fibroid (Fibroid Tumor) A uterine fibroid is a benign (non-cancerous) tumor that grows in the uterine
More informationRole of Robotic Surgery in Obese Women with Endometrial Cancer
Role of Robotic Surgery in Obese Women with Endometrial Cancer Anil Tailor Consultant Gynaecological Oncologist Royal Surrey County Hospital Guildford, Surrey, UK St Peters Hospital Chertsey, Surrey, UK
More informationBridging Techniques. What s between EMR and Traditional Surgery? Elisabeth C. McLemore, MD, FACS, FASCRS
Bridging Techniques What s between EMR and Traditional Surgery? Elisabeth C. McLemore, MD, FACS, FASCRS Associate Professor of Surgery Assistant Program Director, General Surgery Residency Disclosures
More informationConsidering Endometriosis Surgery? Learn about minimally invasive da Vinci Surgery
Considering Endometriosis Surgery? Learn about minimally invasive da Vinci Surgery The Condition: Endometriosis Endometriosis is a condition in which the tissue that lines your uterus (the endometrium)
More informationJanuary 18, 2013. Dear Dr. Schafer,
Medical School Center for Healthcare Outcomes & Policy Bldg 520, Room 31658 2800 Plymouth Rd, SPC 2800 Ann Arbor, Ml48109 (734) 998-7470 (734) 998-7473 fax January 18, 2013 Jyme H. Schafer, MD, MPH Director,
More informationIntuitive Surgical, Inc. (NASDAQ: ISRG) Memo
Name: Haroon Masood College/School: CLAS Year: 2nd Important Company Financial Data Price: 422.62 Market Cap: 16.48B 50W Range: 250.40 449.06 Avg Vol: 396,730 P/E (ttm): 36.50 EPS (ttm): 11.58 Gross Margin
More informationTO SCREEN OR NOT TO SCREEN: THE PROSTATE CANCER
TO SCREEN OR NOT TO SCREEN: THE PROSTATE CANCER DILEMMA Thomas J Stormont MD January 2012 http://www.youtube.com/watch?v=8jd 7bAHVp0A&feature=related related INTRODUCTION A government health panel (the
More informationInvestor Presentation Q4 2015
Investor Presentation Q4 2015 Forward Looking Statement These slides and any accompanying oral presentation by Intuitive Surgical, Inc. contain estimates and forward-looking statements. Actual results
More informationsexual after Being prostate cancer... Manitoba Prostate Centre Visit our website at www.cancercare.mb.ca
Manitoba Prostate Centre Being sexual after prostate cancer... Visit our website at www.cancercare.mb.ca This publication is supported by an unrestricted educational grant from Pfizer Canada Inc. Treatment
More informationRecovery of Erectile Function After Radical Prostatectomy Vanderbilt University Department of Urologic Surgery
Recovery of Erectile Function After Radical Prostatectomy Vanderbilt University Department of Urologic Surgery Postoperative erectile dysfunction is a potential risk of surgery for prostate cancer, whether
More informationPROSTATE CANCER. Get the facts, know your options. Samay Jain, MD, Assistant Professor,The University of Toledo Chief, Division of Urologic Oncology
PROSTATE CANCER Get the facts, know your options Samay Jain, MD, Assistant Professor,The University of Toledo Chief, Division of Urologic Oncology i What is the Prostate? Unfortunately, you have prostate
More informationThe Whipple Operation for Pancreatic Cancer: Optimism vs. Reality. Franklin Wright UCHSC Department of Surgery Grand Rounds September 11, 2006
The Whipple Operation for Pancreatic Cancer: Optimism vs. Reality Franklin Wright UCHSC Department of Surgery Grand Rounds September 11, 2006 Overview Pancreatic ductal adenocarcinoma Pancreaticoduodenectomy
More informationSpecific Standards of Accreditation for Residency Programs in General Surgery
Specific Standards of Accreditation for Residency Programs in General Surgery 2010 INTRODUCTION The purpose of this document is to provide program directors and surveyors with an interpretation of the
More informationQuestions to ask my doctor: About prostate cancer
Questions to ask my doctor: About prostate cancer Being diagnosed with prostate cancer can be scary and stressful. You probably have a lot of questions and concerns. Learning about the disease, how it
More informationProstate Cancer Screening in Taiwan: a must
Prostate Cancer Screening in Taiwan: a must 吳 俊 德 基 隆 長 庚 醫 院 台 灣 醫 學 會 105 th What is the PSA test? The blood level of PSA is often elevated in men with prostate cancer, and the PSA test was originally
More informationScreening for Prostate Cancer
Screening for Prostate Cancer It is now clear that screening for Prostate Cancer discovers the disease at an earlier and more curable stage. It is not yet clear whether this translates into reduced mortality
More informationLaparoscopic Repair of Incisional Hernia. Maria B. ALBUJA-CRUZ, MD University of Colorado Department of Surgery-Grand Rounds
Laparoscopic Repair of Incisional Hernia Maria B. ALBUJA-CRUZ, MD University of Colorado Department of Surgery-Grand Rounds Overview Definition Advantages of Laparoscopic Repair Disadvantages of Open Repair
More informationA Woman s Guide to Prostate Cancer Treatment
A Woman s Guide to Prostate Cancer Treatment Supporting the man in your life Providing prostate cancer support and resources for women and families WOMEN AGAINST PROSTATE CANCER A Woman s Guide to Prostate
More informationSaturation Biopsy for Diagnosis and Staging of Prostate Cancer. Original Policy Date
MP 7.01.101 Saturation Biopsy for Diagnosis and Staging of Prostate Cancer Medical Policy Section Surgery Issue 12/2013 Original Policy Date 12/2013 Last Review Status/Date /12/2013 Return to Medical Policy
More informationIntegrating Chemotherapy and Liver Surgery for the Management of Colorectal Metastases
I Congresso de Oncologia D Or July 5-6, 2013 Integrating Chemotherapy and Liver Surgery for the Management of Colorectal Metastases Michael A. Choti, MD, MBA, FACS Department of Surgery Johns Hopkins University
More informationVATTIKUTI INSTITUTE PROSTATECTOMY (VIP) AND CURRENT RESULTS.
UROLOGY ROBOTIC SURGERY Arch. Esp. Urol., 60, 4 (397-407), 2007 VATTIKUTI INSTITUTE PROSTATECTOMY (VIP) AND CURRENT RESULTS. Mahendra Bhandari and Mani Menon. Vattikuti Urology Institute. Henry Ford Health
More information2010 SITE REPORT St. Joseph Hospital PROSTATE CANCER
2010 SITE REPORT St. Joseph Hospital PROSTATE CANCER Humboldt County is located on the Redwood Coast of Northern California. U.S census data for 2010 reports county population at 134,623, an increase of
More informationHow To Perform Da Vinci Surgery
Facing a Hysterectomy? If you ve been diagnosed with early stage gynecologic cancer, learn about minimally invasive da Vinci Surgery The Condition: Early Stage Gynecologic Cancer A variety of gynecologic
More informationAdvances in Robotic Technology
Advances in Robotic Technology Reza Ghavamian M.D. Professor of Urology Director of Urologic Oncology and Robotic Surgery Montefiore Medical Center Albert Einstein College of Medicine New York Disclosure
More informationQuestions to Ask My Doctor About Prostate Cancer
Questions to Ask My Doctor Being told you have prostate cancer can be scary and stressful. You probably have a lot of questions and concerns. Learning about the disease, how it s treated, and how this
More informationSaturation Biopsy vs. 3D Spatial Biopsy vs. Free Hand Ultrasound biopsy for Targeted Prostate Cancer Therapies
Saturation Biopsy vs. 3D Spatial Biopsy vs. Free Hand Ultrasound biopsy for Targeted Prostate Cancer Therapies John F. Ward, MD Assistant Professor University of Texas M. D. Anderson Cancer Center Ablation
More informationProstatectomy, pelvic lymphadenect. Med age 63 years Mean followup 53 months No other cancer related therapy before recurrence. Negative.
Adjuvante und Salvage Radiotherapie Ludwig Plasswilm Klinik für Radio-Onkologie, KSSG CANCER CONTROL WITH RADICAL PROSTATECTOMY ALONE IN 1,000 CONSECUTIVE PATIENTS 1983 1998 Clinical stage T1 and T2 Mean
More informationPSA Screening and the USPSTF Understanding the Controversy
PSA Screening and the USPSTF Understanding the Controversy Peter C. Albertsen Division of Urology University of Connecticut Farmington, CT, USA USPSTF Final Report 1 Four Key Questions 1. Does PSA based
More informationDISCUSSION ABOUT OPEN, LAPAROSCOPIC, AND ROBOTIC PROSTATECTOMIES MOUNT SINAI MEDICAL CENTER NEW YORK CITY, NEW YORK August 13, 2008
DISCUSSION ABOUT OPEN, LAPAROSCOPIC, AND ROBOTIC PROSTATECTOMIES MOUNT SINAI MEDICAL CENTER NEW YORK CITY, NEW YORK August 13, 2008 00:00:08 ANNOUNCER: Today, Mount Sinai Medical Center s leading urological
More informationIn Practice Whole Body MR for Visualizing Metastatic Prostate Cancer
In Practice Whole Body MR for Visualizing Metastatic Prostate Cancer Prostate cancer is the second most common cancer in men worldwide, accounting for 15% of all new cancer cases. 1 Great strides have
More informationA New Biomarker in Prostate Cancer Care: Oncotype Dx. David M Albala, MD Chief of Urology Crouse Hospital Syracuse, NY
A New Biomarker in Prostate Cancer Care: Oncotype Dx David M Albala, MD Chief of Urology Crouse Hospital Syracuse, NY Learning Objectives Review the current challenges in the prediction and prognosis of
More informationProstate Cancer Patients Report on Benefits of Proton Therapy
Prostate Cancer Patients Report on Benefits of Proton Therapy Dobson DaVanzo & Associates, LLC Vienna, VA 703.260.1760 www.dobsondavanzo.com Prostate Cancer Patients Report on Benefits of Proton Therapy
More informationCancer in Primary Care: Prostate Cancer Screening. How and How often? Should we and in which patients?
Cancer in Primary Care: Prostate Cancer Screening How and How often? Should we and in which patients? PLCO trial (Prostate, Lung, Colorectal and Ovarian) Results In the screening group, rates of compliance
More informationAdvances in Diagnostic and Molecular Testing in Prostate Cancer
Advances in Diagnostic and Molecular Testing in Prostate Cancer Ashley E. Ross MD PhD Assistant Professor Urology, Oncology, Pathology Johns Hopkins School of Medicine September 24, 2015 1 Disclosures
More informationThe PSA Controversy: Defining It, Discussing It, and Coping With It
The PSA Controversy: Defining It, Discussing It, and Coping With It 11 TH ANNUAL SYMPOSIUM ON MEN S HEALTH June 12, 2013 The PSA Controversy Defining It, Discussing It and Coping With It As of May 2012,
More informationClassification of Mixed Incontinence
european urology supplements 5 (2006) 837 841 available at www.sciencedirect.com journal homepage: www.europeanurology.com Classification of Mixed Incontinence Christopher Chapple * Sheffield Hallam University,
More informationAdiuwantowe i neoadiuwantowe leczenie chorych na zaawansowanego raka żołądka
Adiuwantowe i neoadiuwantowe leczenie chorych na zaawansowanego raka żołądka Neoadiuvant and adiuvant therapy for advanced gastric cancer Franco Roviello, IT Neoadjuvant and adjuvant therapy for advanced
More informationReview Article Robot-Assisted Radical Hysterectomy for Cervical Cancer: Review of Surgical and Oncological Outcomes
International Scholarly Research Network ISRN Obstetrics and Gynecology Volume 2011, Article ID 872434, 6 pages doi:10.5402/2011/872434 Review Article Robot-Assisted Radical Hysterectomy for Cervical Cancer:
More informationFocal therapy for prostate cancer: seriously or seriously? Disclosures
Focal therapy for prostate cancer: seriously or seriously? Mitchell Kamrava, MD Assistant Clinical Professor Department of Radiation Oncology University of California Los Angeles Disclosures Speaking honorarium
More informationMINIMALLY INVASIVE SURGERY FOR WOMEN Back to Life. Faster.
MINIMALLY INVASIVE SURGERY FOR WOMEN Back to Life. Faster. Pictured above: UF gynecologists Sharon Byun, MD, Shireen Madani Sims, MD, and Michael Lukowski, MD, with the robotic surgery equipment. Make
More informationThe PLCO Trial Not a comparison of Screening vs no Screening
PSA Screening: Science, Politics and Uncertainty David F. Penson, MD, MPH Hamilton and Howd Chair of Urologic Oncology Professor and Chair, Department of Urologic Surgery Director, Center for Surgical
More informationPreservation and Incorporation of Valuable Endoscopic Innovations (PIVI)
Preservation and Incorporation of Valuable Endoscopic Innovations (PIVI) The American Society for Gastrointestinal Endoscopy PIVI on Endoscopic Bariatric Procedures (short form) Please see related White
More informationda Vinci Mitral Valve Repair
da Vinci Mitral Valve Repair Changing the Experience of Cardiac Surgery Are you a candidate for the latest treatment option for mitral valve disease? Your doctor may be able to offer you a new, minimally
More informationBeyond the PSA: Genomic Testing in Localized Prostate Cancer
Beyond the PSA: Genomic Testing in Localized Prostate Cancer Kelvin A. Moses, MD, PhD Vanderbilt University Medical Center Wednesday, December 2, 2015 5:00 p.m. ET/2:00 p.m. PT About ZERO ZERO s mission
More informationManagement of Peritoneal Metastases (PM) from colorectal cancers: New Perspectives. Dominique ELIAS
Management of Peritoneal Metastases (PM) from colorectal cancers: New Perspectives Dominique ELIAS Declaration of interest BOARDS Congress and teaching 0 Merck 0 Ipsen Novartis Sanofi Trials The peritoneum
More informationThe lungs What is lung cancer? How common is it? Risks & symptoms Diagnosis & treatment options
Why We re Here The lungs What is lung cancer? How common is it? Risks & symptoms Diagnosis & treatment options What Are Lungs? What Do They Do? 1 Located in the chest Allow you to breathe Provide oxygen
More informationProstate-Specific Antigen Based Screening: Controversy and Guidelines
Prostate-Specific Antigen Based Screening: Controversy and Guidelines Eric H. Kim and Gerald L. Andriole Institutional Address: Washington University School of Medicine 4960 Children's Place Campus Box
More informationAn Introduction to PROSTATE CANCER
An Introduction to PROSTATE CANCER Being diagnosed with prostate cancer can be a life-altering experience. It requires making some very difficult decisions about treatments that can affect not only the
More informationConsidering a Hysterectomy?
Considering a Hysterectomy? Learn more about virtually scarless surgery using da Vinci Single-Site technology { {Symptoms & Conditions: Chronic Pain, Heavy Bleeding, Fibroids, Endometriosis, Adenomyosis,
More informationprostate cancer: A Success Story
prostate cancer: A Success Story Prostate cancer is the most common cancer in human beings. That is, even though prostate cancer occurs only in men, the number of men with prostate cancer exceeds the combined
More information